1-3 of 3
natural killer t-cells
Close
Sort by
Journal Articles

Qi S-N, Yang Y, Song Y-Q, et al. First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020;4(13):3141-3153.

Journal: Blood Advances
Blood Adv (2021) 5 (12): 2576.
https://doi.org/10.1182/bloodadvances.2021005072
Published: 2021
Journal Articles

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Toshihito Hirai, Po-Yu Lin, Federico Simonetta, Kristina Maas-Bauer, Mustafa Turkoz, Melissa Mavers, Jeanette Baker, Robert S. Negrin
Journal: Blood Advances
Blood Adv (2021) 5 (11): 2528–2538.
https://doi.org/10.1182/bloodadvances.2020003272
Published: 2021
Includes: Supplemental data
Journal Articles

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Clinical Trials & Observations
Shu-Nan Qi, Yong Yang, Yu-Qin Song, Ying Wang, Xia He, Chen Hu, Li-Ling Zhang, Gang Wu, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Fu-Quan Zhang, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Hui-Qiang Huang, Yu-Jing Zhang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Li-Ming Xu, Zhi-Yong Yuan, Hang Su, Jun Zhu, Ye-Xiong Li
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3141–3153.
https://doi.org/10.1182/bloodadvances.2020001852
Published: 2020
Includes: Supplemental data